Literature DB >> 20827411

Risk factors, genotype 6 prevalence, and clinical characteristics of chronic hepatitis C in Southeast Asian Americans.

Nghia H Nguyen, Philip Vutien, Huy N Trinh, Ruel T Garcia, Long H Nguyen, Huy A Nguyen, Khanh K Nguyen, Mindie H Nguyen.   

Abstract

PURPOSE: Although infection with hepatitis C virus (HCV) affects 32 million individuals from Southeast Asia, little is known about the mode of HCV acquisition and the epidemiology of chronic hepatitis C (CHC) in these individuals. Our goal was to examine risk factors for HCV acquisition, prevalence, and clinical characteristics of HCV genotype 6 compared with genotypes 1 and 2/3 in Southeast Asian (SEA) patients.
METHODS: We performed a cross-sectional study of 308 consecutive SEA Americans with CHC evaluated by five gastroenterologists from January 2000 to December 2008 at two community clinics in northern California via medical record review, using a case report form.
RESULTS: A significant proportion of patients (41%) could not recall any specific risk factors for HCV acquisition. The most commonly reported risk factor in patients who reported at least one risk factor was history of surgeries (34%), followed by blood transfusion (25%) and acupuncture (13%). Among patients with core sequence testing for HCV genotype (n = 181), the most common HCV genotypes were genotype 1 (42%) and genotype 6 (41%), followed by genotype 2/3 (17%). There were no major differences in the clinical and virological characteristics between the different genotype groups (1 vs. 2/3 vs. 6).
CONCLUSION: HCV genotype 6 is as common as genotype 1 in SEAs. Commonly known risk factors for HCV acquisition were not readily identifiable in a large proportion of SEA Americans (41%) and may not be useful in identifying at-risk individuals for HCV screening in this population.

Entities:  

Keywords:  Epidemiology; Genotype 6; HCV; Risk factors; Southeast Asians

Year:  2010        PMID: 20827411      PMCID: PMC2900557          DOI: 10.1007/s12072-010-9181-7

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  29 in total

1.  Ethnic and cultural determinants influence risk assessment for hepatitis C acquisition.

Authors:  Anouk Dev; Vijaya Sundararajan; William Sievert
Journal:  J Gastroenterol Hepatol       Date:  2004-07       Impact factor: 4.029

Review 2.  Hepatocellular carcinoma and hepatitis C in the United States.

Authors:  Hashem B El-Serag
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 3.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

4.  Second-generation line probe assay for hepatitis C virus genotyping.

Authors:  L Stuyver; A Wyseur; W van Arnhem; F Hernandez; G Maertens
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  Interferon and ribavirin therapy for chronic hepatitis C virus genotype 6: a comparison with genotype 1.

Authors:  Chee-Kin Hui; Man-Fung Yuen; Erwin Sablon; Annie On-On Chan; Benjamin Chun-Yu Wong; Ching-Lung Lai
Journal:  J Infect Dis       Date:  2003-03-07       Impact factor: 5.226

6.  Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.

Authors:  M Martinot-Peignoux; P Marcellin; M Pouteau; C Castelnau; N Boyer; M Poliquin; C Degott; I Descombes; V Le Breton; V Milotova
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

7.  Outcome of screening for hepatitis C virus infection based on risk factors.

Authors:  Carol Mallette; Maura A Flynn; Kittichai Promrat
Journal:  Am J Gastroenterol       Date:  2007-09-25       Impact factor: 10.864

8.  Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)

Authors:  T Poynard; P Marcellin; S S Lee; C Niederau; G S Minuk; G Ideo; V Bain; J Heathcote; S Zeuzem; C Trepo; J Albrecht
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

9.  Sequence analysis of the core gene of 14 hepatitis C virus genotypes.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

10.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

View more
  21 in total

Review 1.  Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.

Authors:  Vo Duy Thong; Srunthron Akkarathamrongsin; Kittiyod Poovorawan; Pisit Tangkijvanich; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.

Authors:  Mei-Hsuan Lee; Tiffany I Hsiao; Shreenidhi R Subramaniam; An K Le; Vinh D Vu; Huy N Trinh; Jian Zhang; Mingjuan Jin; Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Mindie H Nguyen
Journal:  Am J Gastroenterol       Date:  2017-04-25       Impact factor: 10.864

3.  Very high prevalence of hepatitis C virus genotype 6 variants in southern Vietnam: large-scale survey based on sequence determination.

Authors:  Van H Pham; Huyen D P Nguyen; Phat T Ho; Dien V Banh; Hoa L T Pham; Phiet H Pham; Ling Lu; Kenji Abe
Journal:  Jpn J Infect Dis       Date:  2011       Impact factor: 1.362

Review 4.  Hepatitis C genotype 6: A concise review and response-guided therapy proposal.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong; Tawesak Tanwandee
Journal:  World J Hepatol       Date:  2013-09-27

5.  Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma.

Authors:  Benjamin Yip; James M Wantuck; Lily H Kim; Robert J Wong; Aijaz Ahmed; Gabriel Garcia; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

6.  Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.

Authors:  Mei Yu; Betty Peng; Katie Chan; Ruoyu Gong; Huiling Yang; William Delaney; Guofeng Cheng
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

7.  Nine additional complete genome sequences of HCV genotype 6 from Vietnam including new subtypes 6xb and 6xc.

Authors:  Chunhua Li; Van H Pham; Kenji Abe; Ling Lu
Journal:  Virology       Date:  2014-08-30       Impact factor: 3.616

8.  Both HCV and HBV are major causes of liver cancer in Southeast Asians.

Authors:  Hillary Lin; Nghiem B Ha; Aijaz Ahmed; Walid Ayoub; Tami J Daugherty; Glen A Lutchman; Gabriel Garcia; Mindie H Nguyen
Journal:  J Immigr Minor Health       Date:  2013-12

9.  HCV Prevalence in Asian Americans in California.

Authors:  Oliver N Lin; Christine Chang; Joyce Lee; Ailinh Do; Marina Martin; Andy Martin; Mindie H Nguyen
Journal:  J Immigr Minor Health       Date:  2017-02

10.  Less-established risk factors are common in Asian Americans with hepatitis C virus: a case-controlled study.

Authors:  Kevin C Kin; Brian Lin; Kevin T Chaung; Nghiem B Ha; Huy N Trinh; Ruel T Garcia; Huy A Nguyen; Khanh K Nguyen; Brian S Levitt; Eduardo B da Silveira; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-10-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.